Transcription of BRIEFING - PharmOut
{{id}} {{{paragraph}}}
BRIEFING 1790 Visual Inspection of Injections. The General Chapters Dosage Forms Expert Committee proposes this new chapter to provide guidance on the inspection of injectable drug products for visible particles. The methods discussed are also applicable to detection of other visible defects that may affect container integrity or cosmetic appearance of the product. (GCDF: D. Hunt.) Correspondence Number C160024 Comment deadline: January 31, 2016 Add the following: 1790 VISUAL INSPECTION OF INJECTIONS 1. SCOPE Introduction Related Chapters Defect Prevention 2. INTRODUCTION Inspection Process Capability Patient Risk History of Compendial Inspection Standards 3. TYPICAL INSPECTION PROCESS FLOW 100% Inspection Acceptance Sampling and Testing Remediation and Alternative Practices 4. INSPECTION LIFE-CYCLE Extrinsic, Intrinsic or Inherent Particles Prevention of Particulates Particulate Removal by Component Washing Trending 5.
Measurement of Subvisible Particulate Matter in Therapeutic Protein Injections 〈1787〉 and Methods for the Determination of Particulate Matter in Injections and Ophthalmic Solutions 〈1788〉 provide additional supporting information on measurement methods for subvisible particles. 1.3 Defect Prevention
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}